Production of interleukin-12 by murine macrophages in response to bacterial peptidoglycan

被引:36
作者
Lawrence, C [1 ]
Nauciel, C [1 ]
机构
[1] Fac Med Paris Ouest, Microbiol Lab, F-92380 Garches, France
关键词
D O I
10.1128/IAI.66.10.4947-4949.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peptidoglycan (PG), a component of the bacterial cell wall, has various immunomodulating activities, including the capacity to induce delayed-type hypersensitivity reactions to antigens administered in Freund's adjuvant. We report that PG induces interleukin-12 (IL-12) mRNA production and IL-12 secretion by mouse macrophages. The capacity of PG to induce IL-12 production, like its previously reported immunomodulating activities, was dependent on the structure of its peptide subunit, PG from Bacillus megaterium and Staphylococcus aureus induced IL-12 production, whereas PG from Micrococcus luteus and Corynebacterium poinsettiae did not. The ability of most bacterial PGs to induce IL-12 production suggests that they play an important role in triggering host defense mechanisms against bacterial infections.
引用
收藏
页码:4947 / 4949
页数:3
相关论文
共 33 条
[1]  
ADAM A, 1981, MOL CELL BIOCHEM, V41, P27
[2]   EFFECTS OF IL-12 ON IMMUNE-RESPONSES TO MICROBIAL INFECTIONS - A KEY MEDIATOR IN REGULATING DISEASE OUTCOME [J].
BIRON, CA ;
GAZZINELLI, RT .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (04) :485-496
[3]  
Bohn E, 1996, J IMMUNOL, V156, P1458
[4]   Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. [J].
Chong, C ;
Bost, KL ;
Clements, JD .
INFECTION AND IMMUNITY, 1996, 64 (04) :1154-1160
[5]  
COOPER AM, 1995, IMMUNOLOGY, V84, P423
[6]  
DAMAIS C, 1975, J IMMUNOL, V115, P268
[7]   PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DANDREA, A ;
RENGARAJU, M ;
VALIANTE, NM ;
CHEHIMI, J ;
KUBIN, M ;
ASTE, M ;
CHAN, SH ;
KOBAYASHI, M ;
YOUNG, D ;
NICKBARG, E ;
CHIZZONITE, R ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1387-1398
[8]  
DZIARSKI R, 1980, J IMMUNOL, V125, P2478
[9]  
DZIARSKI R, 1986, BIOL PROPERTIES PEPT, P229
[10]  
GOGUEL AF, 1982, J NATL CANCER I, V68, P657